GW Pharma’s Enormous Price for Epidiolex

GW Pharma’s Enormous Price for Epidiolex

In a fascinating early August conference call with Seeking Alpha, British-based GW Pharmaceuticals finally revealed their retail price point for CBD-based drug, Epidiolex, as it goes into distribution in the U.S. The drug is designed for the treatment of certain kinds...
LabVantage Launches Cannabis-Specific LIMS

LabVantage Launches Cannabis-Specific LIMS

LabVantage Solutions, known in other testing industries as a leader in laboratory information management systems (LIMS), has launched their own cannabis-specific LIMS. Unveiled at the Cannabis Science Conference in Portland, OR, the purpose-built software is designed...
How to Vet Suppliers in Cannabis Product Manufacturing

How to Vet Suppliers in Cannabis Product Manufacturing

The quality of your edible cannabis product can only be as reliable as the components that comprise it. The three types of components include active ingredients (such as CBD oil), packaging components  (such as the bottles that hold finished product) and inactive...
The Awakening Green Giant: China and Cannabis

The Awakening Green Giant: China and Cannabis

There are many ironies along the path towards global cannabis legalization. Too many to count. But surely one of the oddest was always going to be the reacceptance and relegalization of cannabis in China. The path so far has been, at a minimum, tortured. Ritualistic,...
Are Global Cannabis Markets Moving In Synch?

Are Global Cannabis Markets Moving In Synch?

In American political lingo, an “October Surprise” is an event or incident that is deliberately planned to impact a political election – usually during a presidential year. The cannabis industry, of course, is still highly political – starting with reform itself. So...